Background: Chaihu Guizhi Decoction (CGD) is a classical prescription in traditional Chinese medicine (TCM) that has been shown to be effective against infection and depression. However, the mechanisms of action of CGD in treating patients with depression who are also infected with a virus remain unknown. This study investigated the pharmacological mechanisms of CGD in treating depression-like mice infected with influenza A virus (IAV).
Methods: The acute depression-like mouse model infected with IAV was established. The effects of CGD on alleviating depression-like symptoms were observed using the sucrose preference test and monoamine neurotransmitter expression. Additionally, the effectiveness of CGD against infection was assessed by examining the relative expression of the M gene and pathological changes. To evaluate the anti-inflammatory effects of CGD, the levels of cytokines were measured, and the Th17/Treg ratio was analyzed to evaluate the immunomodulatory effects of CGD.
Results: The study results show that CGD enhanced the rates of sucrose preference and raised the contents of neurotransmitters dopamine (DA) and norepinephrine (NE). CGD treatment led to a reduction in lung index and the relative expression of the M gene, along with improvements in pathological changes caused by IAV. Furthermore, the levels of cytokines were decreased after treatment with CGD, and the imbalance in the ratio of Th17/Treg was corrected via a reduction in the number of Th17 cells after treatment.
Conclusions: CGD has a therapeutic effect in mice with depression-like symptoms infected with IAV, increasing the levels of DA and NE, downregulating M gene expression, calming the cytokine storm, and preserving the homeostasis of Th17/Treg cells.
| [1] |
Harish MM, Ruhatiya RS. Influenza H1N1 infection in immunocompromised host: a concise review. Lung India. 2019;36(4):330-336.
|
| [2] |
Drevets WC, Wittenberg GM, Bullmore ET, Manji HK. Immune targets for therapeutic development in depression: towards precision medicine. Nat Rev Drug Discov. 2022;21(3):224-244.
|
| [3] |
Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain Behav Immun. 2011;25(2):221-229.
|
| [4] |
Zhang H-G, Wang B, Yang Y, et al. Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis. Cell Res. 2022;32(10):897-913.
|
| [5] |
Harper JA, South C, Trivedi MH, Toups MS. Pilot investigation into the sickness response to influenza vaccination in adults: effect of depression and anxiety. Gen Hosp Psychiatry. 2017;48:56-61.
|
| [6] |
Dean DA, Klechka L, Hossain E, et al. Spatial metabolomics reveals localized impact of influenza virus infection on the lung tissue metabolome. mSystems. 2022;7(4):e0035322.
|
| [7] |
Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S. A brief review of influenza virus infection. J Med Virol. 2021;93(8):4638-4646.
|
| [8] |
Liu X, Huuskonen S, Laitinen T, et al. SARS-CoV-2–host proteome interactions for antiviral drug discovery. Mol Syst Biol. 2021;17(11):e10396.
|
| [9] |
Zhang ZJ, Morris-Natschke SL, Cheng YY, Lee KH, Li RT. Development of anti-influenza agents from natural products. Med Res Rev. 2020;40(6):2290-2338.
|
| [10] |
Tian P, Wu J, Tan W, Tian Y. Analysis of Xiaochaihu decoction and its derivation as the ancestor of reconciliation prescription. J Shanxi Univ Chin Med. 2023;24(12):1395-1398.
|
| [11] |
Liu Y, Cao C, Ding H. Study on the anti-depressant effect of Chaihu Guizhi decoction and its mechinisims of actions. Afr J Tradit Complement Altern Med. 2014;11(2):273-276.
|
| [12] |
Han Y, Zhang J, Luo J, et al. Integrating network pharmacology based on UPLC-Q-Exactive/MS technology to explore the mechanism of Chaihu Guizhi decoction in the treatment of secondary bacterial pneumonia caused by influenza. Modern Tradit Chin Med Mater Med-World Sci Technol. 2023;25(6):2111-2121.
|
| [13] |
Zhao L, Qian S, Wang X, et al. UPLC-Q-Exactive/MS based analysis explore the correlation between components variations and anti-influenza virus effect of four quantified extracts of Chaihu Guizhi decoction. J Ethnopharmacol. 2024;319(Pt 3):117318.
|
| [14] |
Zhao J, Yang J, Zhang X, Zheng Q, Rong R, Yang Y. Establishment and evaluation of mice model with liver stagnation and spleen deficiency infected by influenza virus. China J Tradit Chin Med Pharm. 2020;35(7):2602-2607.
|
| [15] |
Zhao Z-X, Fu J, Ma S-R, et al. Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin. Theranostics. 2018;8(21):5945-5959.
|
| [16] |
Liang X, Lin C, Zeng X, et al. Evaluation of spleen-Qi-deficiency rat model induced by reserpine based on Semiquantification of physical signs. Tradit Chin Drug Res Clin Pharmacol. 2019;30(1):26-32.
|
| [17] |
Niu S, Kou S, Zhou X, Ding L. Heshouwu decoction, a Chinese herb for tonifying kidney, ameliorates hypothalamic-pituitary- testicular axis secretion in aging rats. Neural Regen Res. 2012;7(21):1611-1617.
|
| [18] |
Zhang S, Jiang X, Wang Y, et al. Protective effect of An-gong-Niu-Huang Wan pre-treatment against experimental cerebral ischemia injury via regulating GSK-3beta/HO-1 pathway. Front Pharmacol. 2021;12:640297.
|
| [19] |
Zhang YM, Ren HY, Zhao XL, et al. Pharmacokinetics and pharmacodynamics of Da-Cheng-Qi decoction in the liver of rats with severe acute pancreatitis. World J Gastroenterol. 2017;23(8):1367-1374.
|
| [20] |
Liu MY, Yin CY, Zhu LJ, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 2018;13(7):1686-1698.
|
| [21] |
Xu K, Gao P, Liu S, et al. Protective prototype-Beta and Delta-omicron chimeric RBD-dimer vaccines against SARS-CoV-2. Cell. 2022;185(13):2265-2278.e14.
|
| [22] |
Liu M, Yang J, Qian S, et al. Mahuang Xixin Fuzi decoction protects the BALB/c-nude mice infected with influenza A virus by reducing inflammatory cytokines storm and weakly regulating SIgA immune response. J Ethnopharmacol. 2023;304:116070.
|
| [23] |
Nagineni CN, Naz S, Choudhuri R, et al. Radiation-induced senescence reprograms secretory and metabolic pathways in colon cancer HCT-116 cells. Int J Mol Sci. 2021;22(9):4835.
|
| [24] |
Qudus MS, Tian M, Sirajuddin S, et al. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection. J Med Virol. 2023;95(4):e28751.
|
| [25] |
Verstockt B, Salas A, Sands BE, et al. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2023;20(7):433-446.
|
| [26] |
Lorè NI, Bragonzi A, Cigana C. The IL-17A/IL-17RA axis in pulmonary defence and immunopathology. Cytokine Growth Factor Rev. 2016;30:19-27.
|
| [27] |
Cui H, Wang N, Li H, et al. The dynamic shifts of IL-10-producing Th17 and IL-17-producing Treg in health and disease: a crosstalk between ancient “Yin-Yang” theory and modern immunology. Cell Commun Signal. 2024;22(1):99.
|
| [28] |
Fusar-Poli L, Vozza L, Gabbiadini A, et al. Curcumin for depression: a meta-analysis. Crit Rev Food Sci Nutr. 2020;60(15):2643-2653.
|
| [29] |
Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234-256.
|
| [30] |
Hutchinson EC. Influenza virus. Trends Microbiol. 2018;26(9):809-810.
|
| [31] |
Liu W, Tao Z-W, Wang L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020;133(9):1032-1038.
|
| [32] |
Li T, Peng T. Traditional Chinese herbal medicine as a source of molecules with antiviral activity. Antivir Res. 2013;97(1):1-9.
|
| [33] |
Qian S, Liu M, Rong R, Yang Y. Modern research progress of Chaihu Guizhi decoction in treating respiratory diseases. Lishizhen Med Mater Res. 2021;32(5):1210-1213.
|
| [34] |
Markov DD, Novosadova EV. Chronic unpredictable mild stress model of depression: possible sources of poor reproducibility and latent variables. Biology (Basel). 2022;11(11):1621.
|
| [35] |
Jampolska M, Andrzejewski K, Zaremba M, Joniec-Maciejak I, Kaczynska K. Deficiency of biogenic amines modulates the activity of hypoglossal nerve in the reserpine model of Parkinson's disease. Cells. 2021;10(3):531.
|
| [36] |
Willner P. The validity of animal models of depression. Psychopharmacology. 1984;83(1):1-16.
|
| [37] |
Zhang R, Qiao C, Liu Q, et al. A reliable high-throughput screening model for antidepressant. Int J Mol Sci. 2021;22(17):9505.
|
| [38] |
Wei Y, Gao D, Qiao M. Discussion on the mechanism of depression neural circuit from different angles of traditional Chinese and Western medicine. China J Tradit Chin Med Pharm. 2023;38(8):3752-3755.
|
| [39] |
Zeng LF, Cao Y, Wang L, et al. Role of medicinal plants for liver-Qi regulation adjuvant therapy in post-stroke depression: a systematic review of literature. Phytother Res. 2016;31(1):40-52.
|
| [40] |
Chaudhury D, Liu H, Han M-H. Neuronal correlates of depression. Cell Mol Life Sci. 2015;72(24):4825-4848.
|
| [41] |
Patterson L, Rushton SP, Attems J, Thomas AJ, Morris CM. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders. Brain Pathol. 2019;29(4):544-557.
|
| [42] |
Monte-Silva K, Kuo MF, Thirugnanasambandam N, Liebetanz D, Paulus W, Nitsche MA. Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal and nonfocal plasticity in humans. J Neurosci. 2009;29(19):6124-6131.
|
| [43] |
Wang Z, Fang J, Luo J, et al. Antiviral activity of 3D, a butene lactone derivative against influenza A virus in vitro and in vivo. Viruses. 2021;13(2):278.
|
| [44] |
Ledo JH, Azevedo EP, Beckman D, et al. Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer's amyloid-beta oligomers in mice. J Neurosci. 2016;36(48):12106-12116.
|
| [45] |
Dinarello CA. Anti-inflammatory agents: present and future. Cell. 2010;140(6):935-950.
|
| [46] |
Ouyang W, O'Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50(4):871-891.
|
| [47] |
Liao H, Ye J, Gao Y, et al. Baicalein self-microemulsion based on drug–phospholipid complex for the alleviation of cytokine storm. Bioeng Transl Med. 2022;8(1):e10357.
|
| [48] |
Liu C, Xiao K, Xie L. Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS. Front Immunol. 2022;13:922702.
|
| [49] |
Thiel V, Peng Y, Xu R, Zheng X. HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1. PLoS Pathog. 2014;10(4):e1004041.
|
| [50] |
Robinson CM, Wang Y, Pfeiffer JK. Sex-dependent intestinal replication of an enteric virus. J Virol. 2017;91(7):e02101-16.
|
| [51] |
Viox EG, Hoang TN, Upadhyay AA, et al. Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques. Sci Immunol. 2023;8(85):eadg0033.
|
| [52] |
Wilder CL, Lefaudeux D, Mathenge R, et al. A stimulus-contingent positive feedback loop enables IFN-beta dose-dependent activation of pro-inflammatory genes. Mol Syst Biol. 2023;19(5):e11294.
|
| [53] |
Li L, Xu W, Luo Y, et al. Aloe polymeric acemannan inhibits the cytokine storm in mouse pneumonia models by modulating macrophage metabolism. Carbohydr Polym. 2022;297:120032.
|
| [54] |
Yang Y, Tang H. Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol. 2016;13(4):432-442.
|
| [55] |
Kim YK, Na KS, Myint AM, Leonard BE. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;64:277-284.
|
| [56] |
Zador F, Joca S, Nagy-Grocz G, et al. Pro-inflammatory cytokines: potential links between the endocannabinoid system and the kynurenine pathway in depression. Int J Mol Sci. 2021;22(11):5903.
|
| [57] |
Han J, Dai M, Zhao Y, et al. Compatibility effects of ginseng and Ligustrum lucidum Ait herb pair on hematopoietic recovery in mice with cyclophosphamide-induced myelosuppression and its material basis. J Ginseng Res. 2020;44(2):291-299.
|
| [58] |
Chang Y, Zhai L, Peng J, Wu H, Bian Z, Xiao H. Phytochemicals as regulators of Th17/Treg balance in inflammatory bowel diseases. Biomed Pharmacother. 2021;141:111931.
|
| [59] |
Chen P, Tang X. Gut microbiota as regulators of Th17/Treg balance in patients with myasthenia gravis. Front Immunol. 2021;12:803101.
|
| [60] |
Dai H, Zheng R, Wang L, et al. ICS/LABA combined with subcutaneous immunotherapy modulates the Th17/Treg imbalance in asthmatic children. Front Immunol. 2022;13:779072.
|
| [61] |
Wang Y, Li N, Li Q, et al. Xuanbai Chengqi decoction ameliorates pulmonary inflammation via reshaping gut microbiota and rectifying Th17/Treg imbalance in a murine model of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021;16:3317-3335.
|
| [62] |
Wu L, Li D, Qin L, et al. Growth hormone secretagogue receptor deficiency promotes lung cancer growth by affecting the Th17/Treg balance. Ann Transl Med. 2021;9(22):1696.
|
| [63] |
Xia H, Wang F, Wang M, et al. Maresin1 ameliorates acute lung injury induced by sepsis through regulating Th17/Treg balance. Life Sci. 2020;254:117773.
|
| [64] |
Armin S, Safa T, Arshad M, et al. Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls. J Cell Physiol. 2020;236(4):2829-2839.
|
| [65] |
Cui D, Jiang D, Yan C, et al. Immune checkpoint molecules expressed on CD4(+) T cell subsets in chronic asymptomatic hepatitis B virus carriers with hepatitis B e antigen-negative. Front Microbiol. 2022;13:887408.
|
| [66] |
Shi T, Li N, He Y, et al. Th17/Treg cell imbalance plays an important role in respiratory syncytial virus infection compromising asthma tolerance in mice. Microb Pathog. 2021;156:104867.
|
| [67] |
Shi CC, Zhu HY, Li H, et al. Regulating the balance of Th17/Treg cells in gut-lung axis contributed to the therapeutic effect of Houttuynia cordata polysaccharides on H1N1-induced acute lung injury. Int J Biol Macromol. 2020;158:52-66.
|
| [68] |
Nadeem A, Al-Harbi NO, Alfardan AS, Ahmad SF, AlAsmari AF, Al-Harbi MM. IL-17A-induced neutrophilic airway inflammation is mediated by oxidant-antioxidant imbalance and inflammatory cytokines in mice. Biomed Pharmacother. 2018;107:1196-1204.
|
| [69] |
Villegas JA, Bayer AC, Ider K, et al. Il-23/Th17 cell pathway: a promising target to alleviate thymic inflammation maintenance in myasthenia gravis. J Autoimmun. 2019;98:59-73.
|
| [70] |
Wu CC, Liu FL, Sytwu HK, Tsai CY, Chang DM. CD146+ mesenchymal stem cells display greater therapeutic potential than CD146- cells for treating collagen-induced arthritis in mice. Stem Cell Res Ther. 2016;7:23.
|
| [71] |
Sun J, Zhang Q, Yang G, et al. The licorice flavonoid isoliquiritigenin attenuates mycobacterium tuberculosis-induced inflammation through Notch1/NF-kappaB and MAPK signaling pathways. J Ethnopharmacol. 2022;294:115368.
|
| [72] |
Liu S, Li H, Wang Y, et al. High expression of IL-36gamma in influenza patients regulates interferon signaling pathway and causes programmed cell death during influenza virus infection. Front Immunol. 2020;11:552606.
|
| [73] |
Zhang H, Zhang B, Wang X, Pan Y. Discussion of professor Zhang Baoqing's medication rules in treating tic disorders in children based on data mining. Chin Pediatr Integr Tradit West Med. 2024;16(4):349-354.
|
| [74] |
Duan L, Zhang Y, Yang Y, et al. Baicalin inhibits ferroptosis in intracerebral hemorrhage. Front Pharmacol. 2021;12:629379.
|
| [75] |
Geng P, Zhu H, Zhou W, et al. Baicalin inhibits influenza A virus infection via promotion of M1 macrophage polarization. Front Pharmacol. 2020;11:01298.
|
| [76] |
Chen J, Duan M, Zhao Y, et al. Saikosaponin a inhibits influenza A virus replication and lung immunopathology. Oncotarget. 2015;6(40):42541-42556.
|
| [77] |
Hayashi K, Imanishi N, Kashiwayama Y, et al. Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo. Antivir Res. 2007;74(1):1-8.
|
| [78] |
Wolkerstorfer A, Kurz H, Bachhofner N, Szolar OHJ. Glycyrrhizin inhibits influenza A virus uptake into the cell. Antivir Res. 2009;83(2):171-178.
|
RIGHTS & PERMISSIONS
2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.